Retraction Note: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis

Federick C. Cheng,Frederick Gavril D. Leyson,Christessa Emille Que Albay

doi:10.1186/s12883-020-02025-3

Abstract

This article has been retracted. Please see the Retraction Notice for more detail: https://doi.org/10.1186/s12883-020-02025-3

Highlights

The Editor has retracted this article [1]. This was an updated meta-analysis that included two additional studies; one of the studies included in the metaanalysis (Johnson et al 2016, [14] in the article) should not have been included because it reports data comparing Ticagrelor with Aspirin rather than data comparing Ticagrelor plus Aspirin with Aspirin alone
Leyson has not responded to correspondence from the Editor about this retraction
* Correspondence: camillequealbay@gmail.com Cardinal Santos Medical Center, 10 Wilson St. Greenhills West, 1502 San Juan City, NCR, Philippines

Summary

Introduction

The Editor has retracted this article [1]. This was an updated meta-analysis that included two additional studies; one of the studies included in the metaanalysis (Johnson et al 2016, [14] in the article) should not have been included because it reports data comparing Ticagrelor with Aspirin (i.e. mono versus mono antiplatelet therapy) rather than data comparing Ticagrelor plus Aspirin with Aspirin alone (i.e. dual versus mono anti-platelet therapy). Retraction Note: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis

Results

Conclusion